Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications.

Galoppin, Manon; Kari, Saniya; Soldati, Sasha; Pal, Arindam; Rival, Manon; Engelhardt, Britta; Astier, Anne; Thouvenot, Eric (2022). Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications. Brain Communications, 4(4), fcac171. Oxford University Press 10.1093/braincomms/fcac171

[img]
Preview
Text
fcac171.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (2MB) | Preview

Vitamin D deficiency has been associated with the risk of multiple sclerosis, disease activity and progression. Results from in vitro experiments, animal models and analysis of human samples from randomized controlled trials provide comprehensive data illustrating the pleiotropic actions of Vitamin D on the immune system. They globally result in immunomodulation by decreasing differentiation of effector T and B cells while promoting regulatory subsets. Vitamin D also modulates innate immune cells such as macrophages, monocytes and dendritic cells, and acts at the level of the blood-brain barrier reducing immune cell trafficking. Vitamin D exerts additional activity within the central nervous system reducing microglial and astrocytic activation. The immunomodulatory role of Vitamin D detected in animal models of multiple sclerosis has suggested its potential therapeutic use for treating multiple sclerosis. In this review, we focus on recent published data describing the biological effects of Vitamin D in animal models of multiple sclerosis on immune cells, blood-brain barrier function, activation of glial cells and its potential neuroprotective effects. Based on the current knowledge, we also discuss optimization of therapeutic interventions with Vitamin D in patients with multiple sclerosis, as well as new technologies allowing in-depth analysis of immune cell regulations by vitamin D.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Theodor Kocher Institute

UniBE Contributor:

Soldati, Sasha Giulio Natale, Pal, Arindam, Engelhardt, Britta

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2632-1297

Publisher:

Oxford University Press

Language:

English

Submitter:

Pubmed Import

Date Deposited:

12 Jul 2022 14:17

Last Modified:

05 Dec 2022 16:21

Publisher DOI:

10.1093/braincomms/fcac171

PubMed ID:

35813882

Uncontrolled Keywords:

cytokines immunomodulation lymphocytes multiple sclerosis vitamin D

BORIS DOI:

10.48350/171263

URI:

https://boris.unibe.ch/id/eprint/171263

Actions (login required)

Edit item Edit item
Provide Feedback